M R Franz

Author PubWeight™ 71.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Assessment of QT dispersion for prediction of mortality or arrhythmic events after myocardial infarction: results of a prospective, long-term follow-up study. Circulation 1998 2.59
2 Tarantula peptide inhibits atrial fibrillation. Nature 2001 2.38
3 Effect of ischemia on calcium-dependent fluorescence transients in rabbit hearts containing indo 1. Correlation with monophasic action potentials and contraction. Circulation 1988 1.92
4 Monophasic action potential mapping in human subjects with normal electrocardiograms: direct evidence for the genesis of the T wave. Circulation 1987 1.81
5 Targeted disruption of the Kcnq1 gene produces a mouse model of Jervell and Lange-Nielsen Syndrome. Proc Natl Acad Sci U S A 2001 1.76
6 Electrophysiologic features of torsades de pointes: insights from a new isolated rabbit heart model. J Cardiovasc Electrophysiol 1997 1.74
7 Evaluation of a prototype DNA probe test for the noncultural diagnosis of gonorrhea. J Clin Microbiol 1989 1.64
8 In vitro validation of a new cardiac catheter technique for recording monophasic action potentials. Eur Heart J 1986 1.56
9 Prolongation of conduction time during premature stimulation in the human atrium is primarily caused by local stimulus response latency. Eur Heart J 1995 1.55
10 Monophasic action potential recordings from intact mouse heart: validation, regional heterogeneity, and relation to refractoriness. J Cardiovasc Electrophysiol 2001 1.54
11 Electrocardiographic indexes of dispersion of ventricular repolarization: an isolated heart validation study. J Am Coll Cardiol 1995 1.51
12 Shock-induced dispersion of ventricular repolarization: implications for the induction of ventricular fibrillation and the upper limit of vulnerability. J Cardiovasc Electrophysiol 1997 1.49
13 Ischaemia induced alternans of action potential duration in the intact-heart: dependence on coronary flow, preload and cycle length. Eur Heart J 1993 1.46
14 High dispersion of ventricular repolarization after an implantable defibrillator shock predicts induction of ventricular fibrillation as well as unsuccessful defibrillation. J Am Coll Cardiol 2000 1.39
15 Analysis of 12-lead T-wave morphology for risk stratification after myocardial infarction. Circulation 2000 1.30
16 Gadolinium decreases stretch-induced vulnerability to atrial fibrillation. Circulation 2000 1.23
17 Stretch-induced voltage changes in the isolated beating heart: importance of the timing of stretch and implications for stretch-activated ion channels. Cardiovasc Res 1996 1.20
18 Relation between repolarization and refractoriness during programmed electrical stimulation in the human right ventricle. Implications for ventricular tachycardia induction. Circulation 1995 1.14
19 Sudden cardiac death and polymorphous ventricular tachycardia in patients with normal QT intervals and normal systolic cardiac function. Am J Cardiol 1995 1.14
20 Use of the Gen-Probe PACE system for the detection of Neisseria gonorrhoeae in urogenital samples. Diagn Microbiol Infect Dis 1990 1.13
21 Postextrasystolic potentiation of the isolated canine left ventricle. Relationship to mechanical restitution. Circ Res 1985 1.12
22 Long-term recording of monophasic action potentials from human endocardium. Am J Cardiol 1983 1.07
23 Mechanoelectrical feedback: independent role of preload and contractility in modulation of canine ventricular excitability. J Clin Invest 1985 1.06
24 Postrepolarization refractoriness versus conduction slowing caused by class I antiarrhythmic drugs: antiarrhythmic and proarrhythmic effects. Circulation 1998 1.06
25 Electrical and mechanical restitution of the human heart at different rates of stimulation. Circ Res 1983 1.06
26 Dispersion and delay of electrical restitution in the globally ischaemic heart. Eur Heart J 1994 1.03
27 Minimum Information about a Cardiac Electrophysiology Experiment (MICEE): standardised reporting for model reproducibility, interoperability, and data sharing. Prog Biophys Mol Biol 2011 1.03
28 Prolongation of monophasic action potential duration and the refractory period in the human heart by tedisamil, a new potassium-blocking agent. Eur Heart J 1994 1.01
29 Relationships between beat-to-beat interval and the strength of contraction in the healthy and diseased human heart. Circulation 1984 1.00
30 Effects of myocardial ischemia on ventricular fibrillation inducibility and defibrillation efficacy. J Am Coll Cardiol 1997 0.99
31 Myocardial vulnerability to T wave shocks: relation to shock strength, shock coupling interval, and dispersion of ventricular repolarization. J Cardiovasc Electrophysiol 1996 0.97
32 Persistent functional atrioventricular block in two patients with prolonged QT intervals: elucidation of the mechanism of block. Pacing Clin Electrophysiol 1990 0.95
33 The repolarization-excitability relationship in the human right atrium is unaffected by cycle length, recording site and prior arrhythmias. J Am Coll Cardiol 2001 0.93
34 Mechanical restitution of isolated perfused canine left ventricles. Am J Physiol 1984 0.93
35 Relation between repolarization and refractoriness in the human ventricle: cycle length dependence and effect of procainamide. J Am Coll Cardiol 1992 0.91
36 Rate-dependence of QT dispersion and the QT interval: comparison of atrial pacing and exercise testing. J Am Coll Cardiol 2000 0.91
37 Slow and long-lasting modulation of myocardial repolarization produced by ectopic activation in isolated rabbit hearts. Evidence for cardiac "memory". Circulation 1989 0.90
38 Response of relatively refractory canine myocardium to monophasic and biphasic shocks. Circulation 1991 0.89
39 Localization of regional myocardial ischemia by recording of monophasic action potentials. Circulation 1984 0.89
40 Influence of ventricular contractility on non-work-related myocardial oxygen consumption. Heart Vessels 1987 0.89
41 Female gender is a risk factor for torsades de pointes in an in vitro animal model. J Cardiovasc Pharmacol 1999 0.88
42 Improved internal defibrillation efficacy with a biphasic waveform. Am Heart J 1989 0.88
43 Terfenadine increases the QT interval in isolated guinea pig heart. J Cardiovasc Pharmacol 1995 0.87
44 The vulnerable period for low and high energy T-wave shocks: role of dispersion of repolarisation and effect of d-sotalol. Cardiovasc Res 1996 0.86
45 Frequency-dependent antiarrhythmic drug effects on postrepolarization refractoriness and ventricular conduction time in canine ventricular myocardium in vivo. J Pharmacol Exp Ther 1989 0.86
46 Quantitative comparison of the force-interval relationships of the canine right and left ventricles. Circ Res 1984 0.85
47 Reduced arrhythmogenicity of biphasic versus monophasic T-wave shocks. Implications for defibrillation efficacy. Circulation 1996 0.84
48 Comparison of ECG variables of dispersion of ventricular repolarization with direct myocardial repolarization measurements in the human heart. J Cardiovasc Electrophysiol 1998 0.83
49 Mechanism of depolarization in the ischaemic dog heart: discrepancy between T-Q potentials and potassium accumulation. J Physiol 1988 0.83
50 Increased dispersion of ventricular repolarization and ventricular tachyarrhythmias in the globally ischaemic rabbit heart. Eur Heart J 1993 0.81
51 Is dispersion of ventricular repolarization rate dependent? Pacing Clin Electrophysiol 1997 0.81
52 Timing of the upper limit of vulnerability is different for monophasic and biphasic shocks: implications for the determination of the defibrillation threshold. Pacing Clin Electrophysiol 1997 0.80
53 Differential effects of D-sotalol, quinidine, and amiodarone on dispersion of ventricular repolarization in the isolated rabbit heart. J Cardiovasc Electrophysiol 1997 0.80
54 Effect of sustained load on dispersion of ventricular repolarization and conduction time in the isolated intact rabbit heart. J Cardiovasc Electrophysiol 1996 0.80
55 Mechano-electrical feedback. Cardiovasc Res 2000 0.80
56 Summation and inhibition by ultrarapid train pacing in the human ventricle. Circulation 1987 0.79
57 Frequency-dependent effect of quinidine, mexiletine, and their combination on postrepolarization refractoriness in vivo. J Cardiovasc Pharmacol 1989 0.79
58 Dispersion of ventricular repolarization in the voltage domain. Pacing Clin Electrophysiol 1998 0.79
59 In vitro studies of isolated supported human hearts. Heart Vessels 1988 0.78
60 Circadian variation of arrhythmic events, electrophysiological properties, and the autonomic nervous system. Eur Heart J 2001 0.77
61 Sequential pulse internal defibrillation: is there an advantage to "switched" current pathways? Am Heart J 1989 0.77
62 Effects of amiodarone on the circadian pattern of sudden cardiac death (Department of Veterans Affairs Congestive Heart Failure-Survival Trial of Antiarrhythmic Therapy). Am J Cardiol 1997 0.77
63 The electrophysiological basis of QT dispersion: global or local repolarization? Circulation 2000 0.77
64 In vivo electrophysiological detection of myocardial ischemia through monophasic action potential recording. Prog Cardiovasc Dis 1991 0.77
65 QT dispersion as a marker of risk in patients awaiting heart transplantation? J Am Coll Cardiol 1998 0.75
66 Inefficacy and proarrhythmic effects of flecainide and encainide for sustained ventricular tachycardia and ventricular fibrillation. Ann Intern Med 1990 0.75
67 Magnetism: the last resort? J Cardiovasc Electrophysiol 2001 0.75
68 Intramural repolarization differences in the in vivo canine ventricle. J Cardiovasc Electrophysiol 2000 0.75
69 Time for yet another QT correction algorithm? Bazett and beyond. J Am Coll Cardiol 1994 0.75
70 [In vivo registration of monophasic action potentials--new possible applications in clinical electrophysiology]. Z Kardiol 1996 0.75
71 Induction of ventricular fibrillation by T-wave field-shocks in the isolated perfused rabbit heart: role of nonuniform shock responses. Basic Res Cardiol 1997 0.75
72 Ventricular repolarization, T-wave genesis, and risk prediction. Ann Noninvasive Electrocardiol 2001 0.75
73 Electropharmacology of flestolol for supraventricular tachycardia without associated structural heart disease. Am J Cardiol 1987 0.75
74 Immediate quantitation of antiarrhythmic drug effect by monophasic action potential recording in coronary artery disease. Am J Cardiol 1988 0.75
75 New classification of moricizine and propafenone based on electrophysiologic and electrocardiographic data from isolated rabbit heart. J Cardiovasc Pharmacol 1994 0.75
76 Effects of long-term amiodarone treatment on ventricular-fibrillation vulnerability and defibrillation efficacy in response to monophasic and biphasic shocks. J Cardiovasc Pharmacol 1997 0.75
77 N-acetylprocainamide, torsades de pointes, and hemodialysis. Ann Intern Med 1986 0.75
78 Phase angle convergence of multiple monophasic action potential recordings precedes spontaneous termination of ventricular fibrillation. Basic Res Cardiol 1998 0.75
79 [Mechanism of induction and termination of ventricular fibrillation--significance of dispersion of ventricular repolarization]. Z Kardiol 2000 0.75
80 Electrophysiology and antiarrhythmic efficacy of intravenous pirmenol in patients with sustained ventricular tachyarrhythmias. Am Heart J 1987 0.75